Could a heart drug save brain function after a devastating stroke?

NCT ID NCT04362527

Completed Disease control Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a medicine called milrinone, given through a vein, can help people recover better from a serious type of stroke called subarachnoid hemorrhage. After this stroke, many patients develop dangerous spasms in brain arteries that can cause further brain damage. The trial involved 370 adults with this condition and compared milrinone to a placebo to see if it improves recovery at 3 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage intracranial vasospasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VASOSPASM

Contacts and locations

Locations

APHP Lariboisière

Paris, France
CHU Angers

Angers, France
CHU Besançon

Besançon, France
CHU Bordeaux

Bordeaux, France
CHU Brest

Brest, France
CHU Caen

Caen, France
CHU Dijon

Dijon, France
CHU Lille

Lille, France
CHU Nantes

Nantes, France
CHU Rennes

Rennes, France
CHU Tours

Tours, France
Hôpital Civils de Lyon

Lyon, France
Hôpital Fondation ROTHSCHILD

Paris, France
Hôpital Gabriel Montpied

Clermont-Ferrand, France
Hôpital Gui de Chauliac

Montpellier, France
Hôpital de Hautepierre

Strasbourg, 67098, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.